See also this year's filing and all EDGAR filings for this company.
PDF Report 0001829802_2022_Sensei_Biotherapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001829802')"} |
| info | Ambiguous roles for statement | input.sec.calculation_linkbase.expand_agg | {'statement': 'operations', 'valid_roles': {'100050 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS 2': 3, '100070 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 12}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001829802, Sensei Biotherapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 148,542,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,644,000 |
| 3 | remainder_Assets | 39,000 |
| 4 | LiabilitiesCurrent | 4,889,000 |
| 5 | LiabilitiesNoncurrent | 149,000 |
| 6 | remainder_Liabilities | 1,674,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,820,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 22,332,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,358,000 |
| 13 | remainder_ComprehensiveNetIncome | -333,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 153,225,000 |
| 1 | Liabilities | 6,712,000 |
| 2 | Expenses | 38,152,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 146,513,000 |
| 5 | NetIncome | -36,794,000 |
| 6 | ComprehensiveNetIncome | -36,960,500 |
| 7 | BaseVar | 99,890,000 |
| 8 | EconomicCapitalRatio | 2.69 |
Edgar->Model Mapping
Feature Distribution
Change over Time
